Freitas Marcela, Souza Paula, Cardoso Samuel, Cruvinel Kellen, Abrunhosa Letícia Santos, Ferreira Filho Edivaldo X, Inácio João, Pinho Danilo Batista, Pessoa Adalberto, O Magalhães Pérola
Health Sciences School, University of Brasília, Brasília 70910-900, Brazil.
Institute of Biological Sciences, University of Brasília, Brasília 70910-900, Brazil.
Pharmaceutics. 2021 Aug 17;13(8):1268. doi: 10.3390/pharmaceutics13081268.
l-asparaginase is an enzyme used as treatment for acute lymphoblastic leukemia (ALL) due to its ability to hydrolyze l-asparagine, an essential amino acid synthesized by normal cells unlike neoplastic cells. The adverse effects of l-asparaginase formulations are associated with its glutaminase activity and bacterial origin; therefore, it is important to find new sources of l-asparaginase-producing eukaryotic microorganisms with low glutaminase activity. This work evaluated the biotechnological potential of filamentous fungi isolated from Brazilian Savanna soil and plants for l-asparaginase production. Thirty-nine isolates were screened for enzyme production using the plate assay, followed by measuring enzymatic activity in cells after submerged fermentation. The variables influencing l-asparaginase production were evaluated using Plackett-Burman design. Cell disruption methods were evaluated for l-asparaginase release. 2DSST1 and DCFS10 showed the highest l-asparaginase activity levels and the lowest glutaminase activity levels. l-asparaginase was repressed by carbon sources, whereas higher carbon concentrations enhanced l-asparaginase by . Maximum enzyme productivity, specific enzyme yield and the biomass conversion factor in the enzyme increased after Plackett-Burman design. Freeze-grinding released 5-fold more l-asparaginase from cells than sonication. This study shows two species, which have not yet been reported, as sources of l-asparaginase with possible reduced immunogenicity for ALL therapy.
L-天冬酰胺酶是一种酶,因其能够水解L-天冬酰胺而被用作急性淋巴细胞白血病(ALL)的治疗药物。L-天冬酰胺是一种由正常细胞合成的必需氨基酸,与肿瘤细胞不同。L-天冬酰胺酶制剂的不良反应与其谷氨酰胺酶活性和细菌来源有关;因此,寻找谷氨酰胺酶活性低的产生L-天冬酰胺酶的真核微生物新来源很重要。这项工作评估了从巴西热带稀树草原土壤和植物中分离的丝状真菌生产L-天冬酰胺酶的生物技术潜力。使用平板测定法筛选了39株分离株的酶产量,随后在深层发酵后测量细胞中的酶活性。使用Plackett-Burman设计评估影响L-天冬酰胺酶生产的变量。评估了细胞破碎方法对L-天冬酰胺酶释放的影响。2DSST1和DCFS10显示出最高的L-天冬酰胺酶活性水平和最低的谷氨酰胺酶活性水平。碳源会抑制L-天冬酰胺酶的产生,而较高的碳浓度会使L-天冬酰胺酶增加。经过Plackett-Burman设计后,酶的最大生产率、比酶产量和生物量转化因子均有所提高。冷冻研磨从细胞中释放的L-天冬酰胺酶比超声处理多5倍。这项研究表明,有两个尚未报道的物种可作为L-天冬酰胺酶的来源,可能会降低ALL治疗的免疫原性。